Histone chaperone Spt6 is required for class switch recombination but not somatic hypermutation

Activation-induced cytidine deaminase (AID) is shown to be essential and sufficient to induce two genetic alterations in the Ig loci: class switch recombination (CSR) and somatic hypermutation (SHM). However, it is still unknown how a single-molecule AID differentially regulates CSR and SHM. Here we...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 108; no. 19; pp. 7920 - 7925
Main Authors Okazaki, Il-mi, Okawa, Katsuya, Kobayashi, Maki, Yoshikawa, Kiyotsugu, Kawamoto, Shimpei, Nagaoka, Hitoshi, Shinkura, Reiko, Kitawaki, Yoko, Taniguchi, Hisaaki, Natsume, Tohru, Iemura, Shun-Ichiro, Honjo, Tasuku
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 10.05.2011
National Acad Sciences
Subjects
Online AccessGet full text
ISSN0027-8424
1091-6490
1091-6490
DOI10.1073/pnas.1104423108

Cover

Loading…
More Information
Summary:Activation-induced cytidine deaminase (AID) is shown to be essential and sufficient to induce two genetic alterations in the Ig loci: class switch recombination (CSR) and somatic hypermutation (SHM). However, it is still unknown how a single-molecule AID differentially regulates CSR and SHM. Here we identified Spt6 as an AID-interacting protein by yeast two-hybrid screening and immunoprecipitation followed by mass spectrometry. Knockdown of Spt6 resulted in severe reduction of CSR in both the endogenous Ig locus in B cells and an artificial substrate in fibroblast cells. Conversely, knockdown of Spt6 did not reduce but slightly enhanced SHM in an artificial substrate in B cells, indicating that Spt6 is required for AID to induce CSR but not SHM. These results suggest that Spt6 is involved in differential regulation of CSR and SHM by AID.
Bibliography:http://dx.doi.org/10.1073/pnas.1104423108
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
5Present address: Department of Bioscience, Nagahama Institute of Bio-Science and Technology, Shiga 526-0829, Japan.
Author contributions: I.-m.O., K.Y., and T.H. designed research; I.-m.O., K.O., M.K., K.Y., S.K., H.N., Y.K., H.T., T.N., and S.-I.I. performed research; H.N. and R.S. contributed new reagents/analytic tools; I.-m.O. and T.H. analyzed data; and I.-m.O. and T.H. wrote the paper.
4Present address: Laboratory for Mucosal Immunity, RIKEN Research Center for Allergy and Immunology, Yokohama 230-0045, Japan.
Contributed by Tasuku Honjo, April 5, 2011 (sent for review March 4, 2011)
1Present address: Division of Immune Regulation, Institute for Genome Research, University of Tokushima, 770-8503, Japan.
2Present address: Drug Discovery Research Laboratories, Kyowa Hakko Kirin Co., Ltd., Shizuoka 411-8731, Japan.
3Present address: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA 02115.
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.1104423108